Turn Biotechnologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
548 Market St, San Francisco, California...Phone Number
(833) 887-6246Website
turn.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
2
1
About Turn Biotechnologies
Turn Biotechnologies is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA technology combats the effects of aging in the epigenome, thus restoring optimal gene expression and enabling cells to function as vigorously as when they were younger. Established in 2018, Turn Biotechnologies is headquartered in California, United States.Explore more
Turn Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Turn Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Turn Biotechnologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Turn Biotechnologies is spiking on competitors!
Click to see if Turn Biotechnologies had a recent Job posting/layoffs
Check if Turn Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Turn Biotechnologies has new funding data
Turn Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Turn Biotechnologies
Earning: See what the market has to say on Turn Biotechnologies recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Turn Biotechnologies as Masked Content
Find 3 more new buyers
Compare Similar Companies to Turn Biotechnologies
Compare insights from companies similar to Turn Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Turn Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Turn Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Turn Biotechnologies.
Turn Biotechnologies Tech Stack
A closer look at the technologies used by Turn Biotechnologies
Most Recent Scoops
Funding
New Hire
Executive Move
New Hire
Executive Move
Funding
Turn Biotechnologies News & Media
Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for its Epigenetic Reprogramming Therapies
ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can deliver broad range of larger, more varied cargoes – including gene editors, proteins and RNA-based therapies Two delivery technologies make possible...Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for Its Epigenetic Reprogramming Therapies
ARMMs brings precision medicine through targeted, non-viral vesicular delivery. Synergy of ARMMs and eTurna™ LNP platforms means company can deliver broad range of larger, more varied cargoes – including gene editors, proteins and RNA-based therapies. Two delivery technologies make...Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen's microvesicle delivery tech
Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja Krammer aims for 2026 clinical trialsTurn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, announced its latest study to assess the efficacy of using epigenetic reprogramming to rejuvenate bone marrow stem cells. The study, which is being funded by Methuselah Foundation, is the first to evaluat
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Turn Biotechnologies
Sign Up For FreeTo access detailed company insights
Turn Biotechnologies is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA technology combats the effects of aging in the epigenome, thus restoring optimal gene expression and enabling cells to function as vigorously as when they were younger. Established in 2018, Turn Biotechnologies is h... Read More
